Sanofi India Ltd
Alemtuzumab (12mg)
Lemtrada 12mg Infusion is used in the treatment of blood cancer (chronic lymphocytic leukemia) and multiple sclerosis (MS).
Infusion
Lemtrada 12mg Infusion is given under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Rash headache insomnia reduce the number of blood cells (white blood cells) in your blood, thereby increasing the susceptibility to infections or bleeding
It is not known whether it is safe to consume alcohol with Lemtrada 12mg Infusion. Please consult your doctor.
Lemtrada 12mg Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Lemtrada 12mg Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Lemtrada 12mg Infusion is a monoclonal antibody. It flags the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.
Lemtrada 12mg Infusion is given as an injection into the veins under the supervision of a doctor.